41 results
8-K
EX-10.1
inigdbp42i1doh9bpdg5
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-99.1
j86f8 h99g
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-10.1
uu9ruj7l8rqe ms5
20 Mar 20
Immune Therapeutics, Inc. to Collaborate with Cytocom, Inc. to Develop Therapies for COVID-19
11:43am
DRS/A
3t4o xho9atwcyv6xwt
14 Oct 16
Draft registration statement (amended)
12:00am
S-1
gbiyarus b0d
14 Oct 16
IPO registration
12:00am